Literature DB >> 23399397

Current management strategies for verrucous hyperkeratosis and verrucous carcinoma.

James J Sciubba1, Joseph I Helman.   

Abstract

Proliferative verrucous leukoplakia, a lesion of unknown origin with no strictly defined diagnostic criteria, is worthy of great clinical concern and scrutiny. Treatment options vary, with no consensus regarding the most efficient and effective strategy. Further complicating the unusual biology and behavior of this lesion is its usual multifocal presentation and progression, with lifelong vigilance required after treatment. Verrucous carcinoma is a progressive lesion with high recurrence and 5-year survival rates. Surgery remains the preferred treatment. Further investigation into the combination of surgery and antiviral agents may bring additional improvement in patient care.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399397     DOI: 10.1016/j.coms.2012.11.008

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  4 in total

1.  A technical modification of the submental flap for reconstruction of verrucous lesions of the oral cavity.

Authors:  Arvind Krishnamurthy
Journal:  Indian J Surg Oncol       Date:  2013-05-05

2.  Definitive Radiotherapy versus Surgery for the Treatment of Verrucous Carcinoma of the Larynx: A National Cancer Database Study.

Authors:  Anvesh R Kompelli; Michael H Froehlich; Patrick F Morgan; Hong Li; Anand K Sharma; Cherie-Ann O Nathan; David M Neskey
Journal:  Int Arch Otorhinolaryngol       Date:  2021-11-03

3.  Verrucous carcinoma with dysplasia or minimal invasion: a variant of verrucous carcinoma with extremely favorable prognosis.

Authors:  Kalyani R Patel; Rebecca D Chernock; Parul Sinha; Susan Müller; Samir K El-Mofty; James S Lewis
Journal:  Head Neck Pathol       Date:  2014-06-20

4.  Multiple synchronous verrucous carcinomas of the scalp in the background of generalized verruca vulgaris.

Authors:  Arvind Krishnamurthy; Vijayalakshmi Ramshankar; Thangaraj Viveka Soundara; Urmila Majhi
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.